Helga E. De Vries
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications
Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.
Journal: Acta neuropathologica
Published: September 04, 2026
Integrated single-cell RNA sequencing analysis reveals phenotypic differences between blood endothelial cells from oral mucosa and skin.
Journal: European journal of cell biology
Published: February 27, 2026
Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.
Journal: Acta neuropathologica
Published: January 13, 2026
Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.
Journal: Acta neuropathologica
Published: January 13, 2026
Induction of subtle blood-brain barrier dysfunction using preclinical diagnostic ultrasound combined with microbubbles.
Journal: Fluids and barriers of the CNS
Published: November 12, 2025
Measuring blood-brain barrier dysfunction: a critical appraisal of fluid biomarkers, in vitro models, in vivo imaging, and post-mortem approaches.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 20, 2025
Transcriptional and post-transcriptional responses to amyloid-β in cerebral amyloid angiopathy.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: August 07, 2025
Distinct CSF lipidomic profiles are associated with five proteomic subtypes in patients with Alzheimer's disease.
Journal: Molecular neurodegeneration advances
Published: July 17, 2025
Fatty acid binding protein 2 (FATP2/SLC27A2) blockade with Lipofermata elicits dual effects on inflammatory responses in human monocytes and macrophages.
Journal: Immunology letters
Published: May 31, 2025
Last Updated: 09/26/2026